Submit Your Content

Drug developers can't leave identification of potentially lethal organisms to chance

by DuPont Qualicon

In this case study, DuPont Qualicon uses its RiboPrinter Microbial Characterization System to identify an organism in a pharmaceutical company's new asthma inhaler.

Published: 2002
Format: PDF
Length: 2 pages
Type: Case Study
Language: English
.
SPONSORED REPORTS
  • New intravenous drug therapies possible due to Microfluidizer processing
  • Helping cancer patients take their medicine
  • Implementing an infrared thermography maintenance program
  • Online auditing of alarm systems
  • Common hazardous waste issues in the life sciences industry
  • 5x return on investment in the pharmaceutical industry
    • ad

    KnowPharma.com Copyright © 2008, Putman Media, Inc. All rights reserved.
    Designated trademarks and brands are the property of their respective owners.
    Use of this web site constitutes acceptance of the KnowPharma.com Terms and Conditions and Privacy Policy.
    Site Map